{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:55:25Z","timestamp":1788033325529,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10147-020-01668-z","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T10:03:39Z","timestamp":1586426619000},"page":"1432-1439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Utility of whole brain radiation therapy for leptomeningeal carcinomatosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Yasuhiro","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"1668_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1001\/archneur.1974.00490320026003","volume":"30","author":"JR Little","year":"1974","unstructured":"Little JR, Dale AJ, Okazaki H (1974) Meningeal carcinomatosis. clinical manifestations. Arch Neurol 30:138\u2013143","journal-title":"Arch Neurol"},{"key":"1668_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759\u2013772","journal-title":"Cancer"},{"key":"1668_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","volume":"53","author":"M Balm","year":"1996","unstructured":"Balm M, Hammack J (1996) Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 53:626\u2013632","journal-title":"Arch Neurol"},{"key":"1668_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A et al (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9:225\u2013229","journal-title":"J Neurooncol"},{"key":"1668_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1005910203831","volume":"38","author":"G Wolfgang","year":"1998","unstructured":"Wolfgang G, Marcus D, Ulrike S (1998) LC: clinical syndrome in different primaries. J Neurooncol 38:103\u2013110","journal-title":"J Neurooncol"},{"key":"1668_CR6","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","volume":"40","author":"W Boogerd","year":"2004","unstructured":"Boogerd W, van den Bent MJ, Koehler PJ et al (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer 40:2726\u20132733","journal-title":"Eur J Cancer"},{"key":"1668_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fonc.2018.00641","volume":"8","author":"RA El Shafie","year":"2018","unstructured":"El Shafie RA, Bohm K, Weber D et al (2018) Palliative radiotherapy for leptomeningeal carcinomatosis\u2014analysis of outcome, prognostic factors, and symptom response. Front Oncol 8:641","journal-title":"Front Oncol"},{"key":"1668_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jjco\/hyg118","volume":"33","author":"DY Kim","year":"2003","unstructured":"Kim DY, Lee KW, Yun T et al (2003) Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol 33:608\u2013612","journal-title":"Jpn J Clin Oncol"},{"key":"1668_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103\u2013119","journal-title":"Cancer Treat Rev"},{"key":"1668_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/archneurol.2008.506","volume":"66","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain MC, Johnston SK, Glantz MJ (2009) Neoplastic meningitis-related prognostic significance of the Karnofsky performance status. Arch Neurol 66:74\u201378","journal-title":"Arch Neurol"},{"key":"1668_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","volume":"21","author":"H Gauthier","year":"2010","unstructured":"Gauthier H, Guilhaume MN, Bidard FC et al (2010) Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol 21:2183\u20132187","journal-title":"Ann Oncol"},{"key":"1668_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejca.2015.12.021","volume":"56","author":"JW Hyun","year":"2016","unstructured":"Hyun JW, Jeong IH, Joung A et al (2016) Leptomeningeal metastasis: clinical experience of 519 cases. Eur J Cancer 56:107\u2013114","journal-title":"Eur J Cancer"},{"key":"1668_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11060-016-2179-9","volume":"129","author":"Y Ozdemir","year":"2016","unstructured":"Ozdemir Y, Yildirim BA, Topkan E (2016) Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors. J Neurooncol 129:329\u2013335","journal-title":"J Neurooncol"},{"key":"1668_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-008-9758-3","volume":"93","author":"F Waki","year":"2009","unstructured":"Waki F, Ando M, Takashima A et al (2009) Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93:205\u2013212","journal-title":"J Neurooncol"},{"key":"1668_CR15","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1111\/ajco.12597","volume":"13","author":"M Sakaguchi","year":"2017","unstructured":"Sakaguchi M, Maebayashi T, Aizawa T et al (2017) Patient outcomes of whole brain radiotherapy for brain metastases versus leptomeningeal metastases: a retrospective study. Asia Pac J Clin Oncol 13:e449\u2013e457","journal-title":"Asia Pac J Clin Oncol"},{"key":"1668_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745\u2013751","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1668_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.lungcan.2011.11.022","volume":"76","author":"JH Park","year":"2012","unstructured":"Park JH, Kim YJ, Lee JO et al (2012) Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer 76:387\u2013392","journal-title":"Lung Cancer"},{"key":"1668_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.lungcan.2012.03.002","volume":"77","author":"S Umemura","year":"2012","unstructured":"Umemura S, Tsubouchi K, Yoshioka H et al (2012) Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group. Lung Cancer 77:134\u2013139","journal-title":"Lung Cancer"},{"key":"1668_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","volume":"7","author":"PG Morris","year":"2012","unstructured":"Morris PG, Reiner AS, Szenberg OR et al (2012) Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. J Thorac Oncol 7:382\u2013385","journal-title":"J Thorac Oncol"},{"key":"1668_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.lungcan.2013.08.016","volume":"82","author":"T Iuchi","year":"2013","unstructured":"Iuchi T, Shingyoji M, Sakaida T et al (2013) Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma. Lung Cancer 82:282\u2013287","journal-title":"Lung Cancer"},{"key":"1668_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.lungcan.2012.05.092","volume":"77","author":"SJ Park","year":"2012","unstructured":"Park SJ, Kim HT, Lee DH et al (2012) Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. Lung Cancer 77:556\u2013560","journal-title":"Lung Cancer"},{"key":"1668_CR22","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1200\/JCO.2018.78.3118","volume":"36","author":"T Reungwetwattana","year":"2018","unstructured":"Reungwetwattana T, Nakagawa K, Cho BC et al (2018) CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer. J Clin Oncol 36:3290\u20133297","journal-title":"J Clin Oncol"},{"key":"1668_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/neuonc\/now197","volume":"19","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, Junck L, Brandsma D et al (2017) Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol 19:484\u2013492","journal-title":"Neuro Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-020-01668-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T23:34:16Z","timestamp":1617924856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-020-01668-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1668"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01668-z","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"31 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}